The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice

Oncology Research

Volumn 18, Issue 1, 2009, Pages 1-8

  Yang, Yang ^a   Huang, Fang ^a   Ren, Yun ^a   Xing, Lu ^a   Wu, Ying ^a   Li, Zhushi ^a   Pan, Huazhen ^a   Xu, Caimin ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Apoptosis; Apoptotic related proteins; GSH and GPX; Selenomethionine; Sodium selenite; SW480

Indexed keywords

BIM PROTEIN; CASPASE 9; GLUTATHIONE; GLUTATHIONE PEROXIDASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL XL; SELENOMETHIONINE; SODIUM SELENITE; APOPTOSIS REGULATORY PROTEIN; BAD PROTEIN, HUMAN; BCL 2 LIKE PROTEIN 11; BCL-2-LIKE PROTEIN 11; BCL2L1 PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN BCL X;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LOW DRUG DOSE; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT; ANIMAL; BODY WEIGHT; COLORECTAL TUMOR; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; BODY WEIGHT; CASPASE 9; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; MEMBRANE PROTEINS; MICE; MICE, NUDE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SELENOMETHIONINE; SODIUM SELENITE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77950498037     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789745647     Document Type: Article

References (28)

1. Ip, C.; Zhu, Z.; Thompson, H. J.; Lisk, D.; Ganther, H. E. Chemoprevention of mammary cancer with Se-allylsele-nocysteine and other selenoamino acids in the rat. Anticancer Res. 19:2875-2880; 1999.
2. Tirosh, O.; Levy, E.; Reifen, R. High selenium diet protects against TNBS-induced acute inflammation, mitochondrial dysfunction, and secondary necrosis in rat colon. Nutrition 23:878-886; 2007.
3. Corcoran, N. M.; Najdovska, M.; Costello, A. J. Inorganic selenium retards progression of experimental hormone refractory prostate cancer. J. Urol. 171:907-910; 2004.
4. Caffrey, P. B.; Frenkel, G. D. Sensitivity of melphalan-resistant tumors to selenite in vivo. Cancer Lett. 121:177-180; 1997.
5. Watrach, A. M.; Milner, J. A.; Watrach, M. A.; Poirier, K. A. Inhibition of human breast cancer cells by selenium. Cancer Lett. 25:41-47; 1984.
6. Asfour, I. A.; Fayek, M.; Raouf, S.; Soliman, M.; Hegab, H. M.; El-Desoky, H.; Saleh, R.; Moussa, M. A. The impact of high-dose sodium selenite therapy on Bcl-2 expression in adult non-Hodgkin's lymphoma patients: Correlation with response and survival. Biol. Trace Elem. Res. 120:1-10; 2007.
7. Rudolf, E.; Rudolf, K.; Cervinka, M. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells. Cell Biol. Toxicol. 24: 123-141; 2008.
8. Irons, R.; Carison, B. A.; Hatfield, D. L.; Davis, C. D. Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J. Nutr. 136:1311-1317; 2006.
9. Asfour, I. A.; El Shazly, S.; Fayek, M. H.; Hegab, H. M.; Raouf, S.; Moussa, M. A. Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients. Biol. Trace Elem. Res. 110:19-32; 2006.
10. Azrak, R. G.; Cao, S.; Pendyala, L.; Durrani, F. A.; Fakih, M.; Combs, Jr., G. F.; Prey, J.; Smith, P. F.; Rustum, Y. M. Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent. Biochem. Pharmacol. 73:1280-1287; 2007.
11. Cao, S.; Durrani, F. A.; Rustum, Y. M. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin. Cancer Res. 10:2561-2569; 2004.
12. Bordoni, A.; Danesi, F.; Malaguti, M.; Di Nunzio, M.; Pasqui, F.; Maranesi, M.; Luigi Biagi, P. Dietary selenium for the counteraction of oxidative damage: Fortified foods or supplements? Br. J. Nutr. 26:1-7; 2007.
13. Dong, H.; Ying, T.; Li, T.; Cao, T.; Wang, J.; Yuan, J.; Feng, E.; Han, B.; Hua, F.; Yang, Y.; Yuan, J.; Wang, H.; Xu, C. Comparative proteomic analysis of apoptosis induced by sodium selenite in human acute promyelocytic leukemia NB4 cells. J. Cell Biochem. 98:1495-1506; 2006. (Pubitemid 44141854)
14. Zuo, L.; Li, J.; Yang, Y.; Wang, X.; Shen, T.; Xu, C.; Zhang, Z. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Ann. Hematol. 83:751-758; 2004.
15. Li, J.; Zuo, L.; Shen, T.; Xu, C.; Zhang, Z. Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: Involvement of oxidative stress and mitochondria. J. Trace Elem. Med. Biol. 17:19-26; 2003.
16. Strickley, R. G. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21:201-230; 2004.
17. Ip, C.; Thompson, H. J.; Zhu, Z.; Ganther, H. E. In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 60:2882-2886; 2000.
18. Yoon, S. O.; Kim, M. M.; Park, S. J.; Kim, D.; Chung, J.; Chung, A. S. Selenite suppresses hydrogen peroxideinduced cell apoptosis through inhibition of ASK1/JNK and activation of PI3-K/Akt pathways. FASEB J. 16(1):111-113; 2002.
19. Chen, J.; Small-Howard, A.; Yin, A.; Berry, M. J. The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO). Neuroscience 6; 2005.
20. Chandra, J.; Samali, A.; Orrenius, S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 29:323-333; 2000.
21. Hall, A. G. The role of glutathione in hte regulation of apoptosis. Eur. J. Clin. Invest. 29:238-245; 1999.
22. Kim, T. S.; Yun, B. Y.; Kim, I. Y. Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide. Biochem. Pharmacol. 66:2301-2311; 2003.
23. Nilsonne, G.; Sun, X.; Nyström, C.; Rundlöf, A.-K.; Fernandes, A. P.; Björnstedt, M.; Dobra, K. Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress. Free Radic. Biol. Med. 15: 874-885; 2006.
24. Kaushal, N.; Bansal, M. P. Dietary selenium variationinduced oxidative stress modulates CDC2/cyclin B1 expression and apoptosis of germ cells in mice testis. J. Nutr. Biochem. 18:553-564; 2007.
25. Kim, E.; Sohn, S.; Kwon, H.; Kim, S.; Kim, M.-J.; Lee, S.-J.; Choi, K. Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res. 67: 6314-6324; 2007.
26. Uhm, S. J.; Gupta, M. K.; Yang, J. H.; Lee, S. H.; Lee, H. T. Selenium improves the developmental ability and reduces the apoptosis in porcine parthenotes. Mol. Reprod. 74:1386-1394; 2007.
27. Zhao, R.; Domann, F. E.; Zhong, W. Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells. Mol. Cancer Ther. 5:3275-3284; 2006.
28. Singh, M.; Sharma, H.; Singh, N. Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondrion 7:367-373; 2007.